{"qas": [{"question": "How many antibiotics have been created in the last 7 years?", "id": "5733d88b4776f41900661344", "answers": [{"text": "2", "answer_start": 192}], "is_impossible": false}, {"question": "How many are in the pipelin to fight GNB?", "id": "5733d88b4776f41900661345", "answers": [{"text": "seven", "answer_start": 353}], "is_impossible": false}, {"question": "What year did the Infectious Disease Society of America say that production of new antibiotics does not keep up with resistance?", "id": "5733d88b4776f41900661346", "answers": [{"text": "2013", "answer_start": 9}], "is_impossible": false}, {"plausible_answers": [{"text": "2", "answer_start": 192}], "question": "How many bacilli have been created in the last 7 years?", "id": "5a65ed7bc2b11c001a425e01", "answers": [], "is_impossible": true}, {"plausible_answers": [{"text": "seven", "answer_start": 353}], "question": "How many are in the pipeline to fight IDSA?", "id": "5a65ed7bc2b11c001a425e02", "answers": [], "is_impossible": true}, {"plausible_answers": [{"text": "2013", "answer_start": 9}], "question": "What year did the Infectious Diseases of America say that production of GNB does not keep up with resistance?", "id": "5a65ed7bc2b11c001a425e03", "answers": [], "is_impossible": true}, {"plausible_answers": [{"text": "declines continuously", "answer_start": 308}], "question": "What happens to the umber of new resistance?", "id": "5a65ed7bc2b11c001a425e04", "answers": [], "is_impossible": true}, {"plausible_answers": [{"text": "antibiotics", "answer_start": 359}], "question": "What drugs address teh entire spectrum of resistance of GNB?", "id": "5a65ed7bc2b11c001a425e05", "answers": [], "is_impossible": true}], "context": "In April <a2_0><b5_0>2013<b5_0/><a2_0/>, the Infectious Disease Society of America (IDSA) reported that the weak antibiotic pipeline does not match bacteria's increasing ability to develop resistance. Since 2009, only <a0_0><b3_0>2<b3_0/><a0_0/> new antibiotics were approved in the United States. The number of new antibiotics approved for marketing per year <b6_0>declines continuously<b6_0/>. The report identified <a1_0><b4_0>seven<b4_0/><a1_0/> <b7_0>antibiotics<b7_0/> against the Gram-negative bacilli (GNB) currently in phase 2 or phase 3 clinical trials. However, these drugs do not address the entire spectrum of resistance of GNB. Some of these antibiotics are combination of existent treatments:"}